Institutional investors adjust holdings in Denali Therapeutics and Delta Air Lines

Institutional investors have recently adjusted their positions in Denali Therapeutics Inc. and Delta Air Lines, Inc., according to recent SEC filings.

Sei Investments Co. acquired 52,235 shares of Denali Therapeutics Inc. during the first quarter, a position valued at approximately $1,003,000. Other major moves include Pictet Asset Management Holding SA significantly increasing its stake and UBS Group AG lifting its holdings in the biotechnology firm. Institutional investors currently own 92.92% of Denali Therapeutics stock.

In the transportation sector, Revolve Wealth Partners LLC established a new position in Delta Air Lines, Inc. during the second quarter, purchasing 14,721 shares valued at roughly $1,379,000. Other firms, including Elevation Wealth Partners LLC and Cornerstone Planning Group LLC, also reported changes to their Delta Air Lines holdings. Institutional investors and hedge funds hold 69.93% of the airline's stock.